How Long Until My GLP-1 Starts Working?
Written by Evergreen Editorial, Evergreen Telehealth
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth
Published Updated

Quick Answer
Many people notice subtle appetite changes within the first one to two weeks, but the first one to two months work mostly like a warm-up period, getting your body used to the medication, with more noticeable, measurable results typically building around the 8 to 12 week mark as your dose increases. Results then tend to continue building over the following months before leveling off. Side effects, most commonly digestive, are common during this same early period; see our full side-effects breakdown.
One of the most common questions people ask after their first dose is some version of: “Is this supposed to be working yet?” The honest answer is that GLP-1s work on a timeline, not a switch, and knowing what to expect at each stage can make the early weeks a lot less confusing.
2–4% body weight
Mild appetite change
Appetite quiets down
1–2 lbs/week loss
15–25% total loss
Plateau is normal
When Will I Feel Anything at All?
Many people notice changes in appetite and fullness within the first one to two weeks, even at a starting dose. This is usually subtle: feeling satisfied with less food, thinking about food less often, or noticing you stop eating sooner than you used to. It's rarely dramatic in the first days, and it isn't supposed to be. Starting doses are intentionally low to let your body adjust before increasing further.
What Happens in the First One to Two Months?
It helps to think of the first one to two months as a warm-up period rather than the main event. Starting doses are deliberately small, too low to drive significant weight loss on their own, because their job at this stage is to let your body adjust to the medication before the dose increases further. Some people notice little appetite change yet during this window, and mild digestive side effects can show up without much happening on the scale, which can feel discouraging if you don't know to expect it. On average, weight loss during these first two months is modest, often in the range of 2 to 4 percent of body weight.
When Do Most People Start Seeing Meaningful Results?
For weight-related outcomes specifically, clinical trials of GLP-1 medications have generally shown meaningful, measurable change becoming apparent around the 8 to 12 week mark, once the dose has been titrated upward a few times, though individual results vary. As the dose climbs into this range, many people describe a noticeable shift: appetite drops more clearly, food-related thoughts quiet down, and weight loss picks up pace compared to the first couple of months, often to somewhere around 1 to 2 pounds per week during this acceleration phase.
For blood sugar-related outcomes, some effects on glucose control can show up earlier, sometimes within the first few weeks, even before the dose has reached its target level.
What Happens After the First Few Months?
Weight loss generally continues through months six to twelve, though the pace tends to slow compared to the acceleration seen around months three and four. By somewhere in the twelve-to-eighteen-month range, many people reach a plateau. In major clinical trials, average total weight loss has been reported in the range of roughly 15 to 17 percent of body weight for semaglutide and roughly 20 to 25 percent for tirzepatide, though individual results vary considerably and some people lose more or less than these averages.
Does Everyone Respond at the Same Pace?
No. Response to GLP-1 medications varies significantly from person to person. Some people notice meaningful change earlier and more strongly than average, while others respond more gradually, or find their result plateaus at a lower dose than the maximum. A smaller group of people don't see a strong response even at a full dose, which doesn't mean anything went wrong. It more often reflects individual biology or other underlying factors, and it's a reason to talk with your prescriber about next steps rather than a sign to give up.
Why Does It Take Longer Than People Expect?
A few reasons:
- Titration is deliberate. Starting at a low dose and increasing gradually reduces side effects, but it also means the full effect isn't reached until you're further into the schedule.
- The mechanism itself is gradual. GLP-1s work by affecting appetite signaling and digestion speed, not by any kind of immediate, one-time action.
- Individual response varies. Metabolism, starting point, dose, and other individual factors all affect how quickly someone notices change, so a friend's timeline isn't necessarily yours.
What If I Don't Notice Anything After a Month?
This is worth raising with your clinician rather than assuming something is wrong. It could mean you're still early in the titration schedule, that a dose adjustment makes sense, or simply that your response curve looks different from someone else's. It's a conversation, not a verdict.
Does the Medication Stop Working After a While?
Reaching a plateau, often somewhere in the twelve-to-eighteen-month range, is a normal part of how these medications work over time, not a sign that something has failed. It generally reflects your body settling into a new balance between intake and energy needs at your new weight, and it's often addressed through dose adjustments or a broader look at diet and activity alongside the medication. This is exactly the kind of thing an ongoing relationship with a prescribing clinician is for. Protecting muscle mass along the way, through adequate protein and regular resistance exercise, also supports longer-term results; see our guide to protecting muscle on a GLP-1 →
For a deeper dive into how GLP-1 therapy works and what to expect, read our Complete Guide to GLP-1 Weight Loss Treatment →
Interested in getting started? Check your eligibility →
Frequently Asked Questions
Will I feel side effects before I feel any benefits?
Often, yes. Digestive side effects tend to show up early, sometimes before appetite changes become noticeable, which is part of why the first few weeks can feel disorienting.
Does taking a higher dose make it work faster?
Not necessarily. Doses are increased on a schedule designed around tolerability, not speed, and jumping ahead of that schedule isn't something to do without your clinician's guidance.
How long does the typical dose increase schedule take?
This varies by specific medication and individual response. Your prescribing clinician will lay out the specific schedule for what you've been prescribed.
Is it normal to feel nothing at all in the first two weeks?
Yes. Many people don't notice clear changes until they've moved past the starting dose, so feeling nothing right away isn't unusual or a sign the medication isn't going to work.
What should I do if I hit a plateau?
Bring it up with your clinician. A plateau is common and is often addressed through a dose adjustment or a look at other factors like diet and activity, rather than a sign to stop treatment.
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Rubino DM, Greenway FL, Khalid U, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021;325(14):1414-1425.
- Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity. Nat Med. 2022;28(10):2083-2091.
- Wharton S, Davies M, Dicker D, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14-19.
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth, on September 4, 2026.
This article is for general educational purposes and is not a substitute for individualized medical advice. Timelines vary by individual and by medication. Talk with your prescribing clinician about what to expect for your specific treatment plan.
Information and statements on this material have not been evaluated by the Food and Drug Administration. Evergreen Telehealth content is for general education and should never replace professional medical advice that considers your individual health.